Cboe Global Markets (CBOE)
(Delayed Data from AMEX)
$205.40 USD
-1.69 (-0.82%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $206.98 +1.58 (0.77%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
CBOE Global (CBOE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$200.20 | $230.00 | $180.00 | -3.33% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for CBOE Global comes to $200.20. The forecasts range from a low of $180.00 to a high of $230.00. The average price target represents a decline of 3.33% from the last closing price of $207.09.
Analyst Price Targets (15)
Broker Rating
CBOE Global currently has an average brokerage recommendation (ABR) of 2.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on 16 recommendations.
Of the 16 recommendations deriving the current ABR, five are Strong Buy, representing 31.25% of all recommendations. A month ago, Strong Buy represented 31.25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 11 | 11 | 10 | 10 | 10 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 1 | 1 | 1 |
ABR | 2.38 | 2.38 | 2.50 | 2.50 | 2.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/28/2024 | Not Identified | Not Identified | Hold | Hold |
8/8/2024 | Not Identified | Not Identified | Hold | Hold |
8/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/5/2024 | UBS | Alex Kramm | Hold | Hold |
8/4/2024 | Keefe Bruyette & Woods | Kyle K Voigt | Hold | Hold |
7/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/10/2024 | Not Identified | Not Identified | Hold | Hold |
7/9/2024 | Piper Sandler | Patrick Moley | Strong Buy | Strong Buy |
7/9/2024 | Goldman Sachs | Alexander Blostein | Hold | Hold |
5/16/2024 | Atlantic Equities | Russell Quelch | Not Available | Hold |
5/6/2024 | Rosenblatt Securities | Andrew Bond | Strong Buy | Strong Buy |
11/16/2023 | Argus Research Corp. | Kevin M Heal | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.38 |
ABR (Last week) | 2.38 |
# of Recs in ABR | 16 |
Average Target Price | $200.20 |
LT Growth Rate | 13.80% |
Industry | Securities and Exchanges |
Industry Rank by ABR | 159 of 253 |
Current Quarter EPS Est: | 2.13 |